Document is current
Any future updates will be listed below
-
Authors
Tamir, Hadas
Noy-Porat, Tal https://orcid.org/0000-0001-5543-8358
Melamed, Sharon
Cherry-Mimran, Lilach
Barlev-Gross, Moria
Alcalay, Ron
Yahalom-Ronen, Yfat
Achdout, Hagit https://orcid.org/0000-0003-0664-8628
Politi, Boaz
Erez, Noam https://orcid.org/0000-0001-5241-8028
Weiss, Shay
Rosenfeld, Ronit https://orcid.org/0000-0002-3990-8695
Epstein, Eyal
Mazor, Ohad https://orcid.org/0000-0001-5956-9865
Makdasi, Efi
Paran, Nir https://orcid.org/0000-0001-5143-9660
Israely, Tomer https://orcid.org/0000-0003-0246-4477
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 27 March 2024
First Online: 16 April 2024
Competing interests
: Patent application (PCT/IL2024/050198) for the described antibodies was filed by the Israel Institute for Biological Research. The patent covers the sequence and use of these antibodies. There is no restriction on data publication. H.T., T.N.P., S.M., N.P., E.M., R.E, R.R, O.M and T.I. are inventors of this patent application. The remaining authors declare no competing interests.
